Clincosm LogoSign in Get a demo

Micro-RNA Expression Profiles in Localised Prostate Cancer

Sponsor
Wuerzburg University Hospital (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03338712
Collaborator
(none)
0
Enrollment
74
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Recurrence free survival The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    0 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Micro-RNA Expression Profiles in Localised Prostate Cancer
    Anticipated Study Start Date :
    Feb 1, 2010
    Anticipated Primary Completion Date :
    Apr 1, 2016
    Anticipated Study Completion Date :
    Apr 1, 2016

    Outcome Measures

    Primary Outcome Measures

    1. Recurrence free survival [Up to 120 months. From date of inclusion until date of death from any cause]

      The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association.

    Secondary Outcome Measures

    1. Cancer specific survival [Up to 120 months. From date of inclusion until date of death from any cause]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • 35 Years to 80 Years

    • Male

    • Patients with clinically localised high risk prostate cancer

    Exclusion Criteria:

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Wuerzburg University Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Wuerzburg University Hospital
    ClinicalTrials.gov Identifier:
    NCT03338712
    Other Study ID Numbers:
    • mi-RNA-PCa
    First Posted:
    Nov 9, 2017
    Last Update Posted:
    Nov 9, 2017
    Last Verified:
    Nov 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Additional relevant MeSH terms:
    Prostatic Neoplasms

    Study Results

    No Results Posted as of Nov 9, 2017